Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€541.4 million)- 142nd in Top Companies
- 19th in Health
- 17th in Pharma
By Employees
(2,000)- 124th in Top Companies
- 21st in Health
- 11th in Pharma
-
- 2,000
- €541.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- Sep 22 Beef protests likely to end following votes to call off blockades
- Sep 22 RHA annual exhibition hits 11-year high in sales
- Sep 22 RHA annual art exhibition hits 11-year high in sales
- Sep 22 Cash-strapped RTÉ examines options for transmission network unit
- Sep 21 ’Team of us’ campaign central to building buzz around rugby team - IRFU